Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Dupilumab in Adult Indian Patients With Moderate-to-severe Atopic Dermatitis
NCT07905547Phase 4Not yet recruiting
- Sponsor
- Sanofi
- Start
- Oct 2026
- Primary completion
- Feb 2027
01
Overview
A Phase 4 trial of dupilumab in atopic dermatitis (AD), sponsored by Sanofi. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07905547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07905547.